A prospective, non-interventional, observational, multi-center trial to evaluate compliance and efficacy in mono and combination treatment of Candesartan cilexetil(Atancand)/ Candesartan cilexetil 16mg, hydrochlorothiazide 12.5mg(Atancand plus) in hypertension.

Study identifier:NIS-CKR-ATA-2007/9

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A prospective, non-interventional, observational, multi-center trial to evaluate compliance and efficacy in mono and combination treatment of Candesartan cilexetil(Atancand)/ Candesartan cilexetil 16mg, hydrochlorothiazide 12.5mg(Atancand plus) in hypertension.

Medical condition

hypertension

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Observational

Age

-

Date

Study Start Date: 01 Jun 2007
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria